Ebersberg, Germany, January 23th, 2014 - Eurofins MWG Operon, a leader in next generation sequencing services has expanded its exome sequencing services with the Ion Proton Next Generation Sequencer.
Certification for Ion AmpliSeq Exome sequencing was also awarded after joining Life Technologies Corporation's Ion AmpliSeq Exome Certified Service Provider (CSP) program. Membership in Life Technologies' CSP program is exclusive and comprises of a select group of genomic service providers worldwide who meet the standards set by Ion Torrent for delivering high-quality sequence data.
Using Life Technologies proprietary approach, consisting of the Ion AmpliSeq Exome Kit, the Ion Proton Sequencer and Ion Reporter Software, provides researchers with the fastest, most cost-effective exome sequencing solution available with flexible throughput on the market today. "Eurofins MWG Operon is pleased to gain exome certification allowing us to offer Life Technologies Ion Proton exome sequencing services to our global customers. This will further aid researchers in their quest to identify disease-causing genes", said Bruno Poddevin, Vice President of Eurofins MWG Operon.
For complete details about Eurofins MWG Operon's exome sequencing service, visit our web page at http://www.eurofinsgenomics.eu/exomes.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.